Lysine Methyltransferase 5B (KMT5B), a methyltransferase targeting histone H3K4, promotes transcriptional activation and has been implicated as a risk gene in autism spectrum disorders (Bao et al. 2024). This evidence concerns the gene KMT5B and autism spectrum disorder.